Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Vitreous Hemorrhage in PDR (Protocol N)
NCT00996437Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Jun 2010
- Primary completion
- Feb 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in proliferative diabetic retinopathy (PDR), Vitreous hemorrhage (VH), sponsored by Jaeb Center for Health Research. Started Jun 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)Vitreous hemorrhage (VH)
Beyond the preview
Go deeper on NCT00996437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996437.